Neonatal ocular prophylaxis in the United States: is it still necessary?

References

• Credé CSF. Die Verhuetung der Augenentzundung der Neugeborenen [Prevention of inflammatory eye disease in the newborn]. Arch Gynaekol. 1881;18:367–370.
   Google Scholar
• Thygeson P, Stone W Jr. Epidemiology of inclusion conjunctivitis. Arch Ophthalmol. 1942;27(1):91–122.
   Google Scholar
• Kardos N, Demain AL. Penicillin: the medicine with the greatest impact on therapeutic outcomes. Appl Microbiol Biotechnol. 2011;92(4):677–687.
   PubMed Web of Science ®Google Scholar
• Brockelhurst P. Antibiotics for gonorrhoeae in pregnancy. Cochrane Database Syst Rev. 2002;2:CD000098.
   PubMedGoogle Scholar
• Worboys MC: A Disease without a HistoryThe Hidden Affliction: Sexually Transmitted Infections and Infertility in History. In: Szreter S, editor. A Disease without a HistoryThe Hidden Affliction: Sexually Transmitted Infections and Infertility in History. Rochester (NY): University of Rochester Press; 2019 Oct. Chapter Five. pp. 153–156.
   Google Scholar
• Hammerschlag MR, Kohlhoff S. Infections Caused by Chlamydia. In: Cherry J, Demmler-Harrison GJ, Kaplan SL, et al., editors. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases. 7th ed. Pennsylvania: Elsevier; 2014. p. 2631–2637.
   Google Scholar
• Hammerschlag MR, Smith-Norowitz TA, Kohlhoff SA. Keeping an eye on chlamydia and gonorrhea conjunctivitis in infants in the United States, 2010-2015. Sex Transm Dis. 2017;44(9):577.
   PubMed Web of Science ®Google Scholar
• Schachter J, Grossman M, Holt J, et al. Prospective study of chlamydial infection in neonates. Lancet. 1979;2(8139):377–380.
   PubMed Web of Science ®Google Scholar
• Hammerschlag MR, Anderka M, Semine DZ, et al. Prospective study of maternal and infantile infection with Chlamydia trachomatis. Pediatrics. 1979;64(2):142–148.
   PubMed Web of Science ®Google Scholar
• Chandler JW, Alexander ER, Pheiffer TA, et al. Ophthalmia neonatorum associated with maternal chlamydial infection. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:302–308.
   Google Scholar
• Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Recomm Rep. 1993;42(RR–12):1–8.
   Google Scholar
• Smith-Norowitz T, Ukaegbu C, Kohlhoff S, et al. Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns. BMC Infect Dis. 2021;21(1):270.
   PubMed Web of Science ®Google Scholar
• Hammerschlag MR, Chandler JW, Alexander ER, et al. Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. JAMA. 1980;244(20):2291–2293.
   PubMed Web of Science ®Google Scholar
• Hammerschlag MR, Cummings C, Roblin PM, et al. Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med. 1989;320(12):769–772.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(RR–4):1–192.
   Web of Science ®Google Scholar
• Curry SJ, Krist AH, Owens DK, US Preventative Services Task Force. Ocular prophylaxis for gonococcal ophthalmia neonatorum US preventative services task force reaffirmation recommendation statement. JAMA. 2019;321(4):394–398.
   PubMed Web of Science ®Google Scholar
• WHO Guidelines for the treatment of Neisseria gonorrhoeae. PMID: 27512795 Bookshelf ID: NBK379221. Accessed 2022 Sept 25.
   Google Scholar
• Darling EK, McDonald H. A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum. J Midwifery Womens Health. 2010;55(4):319–327.
   PubMed Web of Science ®Google Scholar
• Moore DL, MacDonald NE. Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Preventing ophthalmia neonatorum. Paediatr Child Health. 2015;20(2):93–96.
   PubMedGoogle Scholar
• Derbie A, Mekonnen D, Woldeamanuel Y, et al. Azithromycin resistant gonococci: a literature review. Antimicrob Resist Infect Control. 2020;9(1):138.
   PubMed Web of Science ®Google Scholar
• Bremond-Gignac, Bremond-Gignac D, Chiambaretta F, et al. A European perspective on topical ophthalmic antibiotics: current and evolving options. Ophthalmol Eye Dis. 2011;3:29–43.
   PubMedGoogle Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587–613.
   PubMed Web of Science ®Google Scholar
• Slaney L, Chubb H, Ronald A, et al. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother. 1990;25(suppl A):1–5.
   PubMedGoogle Scholar
• Holderman JL, Thomas JC, Schlanger K, et al. Sustained transmission of Neisseria gonorrhoeae with high-level resistance to azithromycin, in Indianapolis, Indiana, 2017-2018. Clin Infect Dis. 2021;73(5):808–815.
   PubMed Web of Science ®Google Scholar
• National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae–2015. https://www.canada.ca/en/public-health/services/publications/drugs-health-products/national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html. Published 2015. Accessed Oct 12, 2022.
   Google Scholar
• Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR–03):1–137. Erratum in: MMWR Recomm Rep. 2015;64(33):924.
   PubMed Web of Science ®Google Scholar
• St Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s treatment guidelines for gonococcal infection, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1911–1916.
   PubMed Web of Science ®Google Scholar
• Zar HJ. Neonatal chlamydial infections prevention and treatment. Pediatr Drugs. 2005;7(2):103–110.
   PubMedGoogle Scholar
• Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis. 1995;20(1):S47–S65.
   PubMedGoogle Scholar
• Lahra MM, Shoushtari M, George CRR, et al. National Neisseria Network, Australia. Australian Gonococcal Surveillance Programme annual report, 2019. Commun Dis Intell. 2020;15:44.
   Google Scholar
• Young H, Moyes A, McMillan A. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS. 1997;8(5):299–302.
   PubMed Web of Science ®Google Scholar
• Kirkcaldy RD, Harvey A, Papp JR, et al. Neisseria gonorrhoeae antimicrobial susceptibility surveillance - The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014. MMWR Surveill Summ. 2016;65(7):1–19.
   PubMed Web of Science ®Google Scholar
• Selb R, Buder S, Dudareva S, et al. Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021. Euro Surveill. 2021;26(31):2100616.
   PubMedGoogle Scholar
• SURRG Working Group, Gieseker KE, Learner ER, Mauk K, et al. Demographic and epidemiological characteristics associated with reduced antimicrobial susceptibility to Neisseria gonorrhoeae in the United States, strengthening the US response to resistant gonorrhea, 2018 to 2019. Sex Transm Dis. 2021;48(12S):S118–S123.
   PubMed Web of Science ®Google Scholar
• Benamri I, Azzouzi M, Sanak K, et al. An overview of genes and mutations associated with Chlamydiae species’ resistance to antibiotics. Ann Clin Microbiol Antimicrob. 2021;20(591):1–11.
   PubMedGoogle Scholar
• Hammerschlag MR, Sharma R. Azithromycin in the treatment of rectogenital Chlamydia trachomatis infections: end of an era? Expert Rev Anti Infect Ther. 2020;19(4):487–493.
   PubMedGoogle Scholar
• Kong FYS, Horner P, Unemo M, et al. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J Antimicrob Chemother. 2019;74(5):1157–1166.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kitagawa Y, Maruyama Y, et al. Conjunctivitis caused by Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility and multidrug resistance. J Clin Microbiol. 2013;51(12):4246–4248.
   PubMed Web of Science ®Google Scholar
• Agrahari V, Mandal A, Agrahari V, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6(6):735–754.
   PubMed Web of Science ®Google Scholar
• Isenberg SJ, Apt L, McCarty J, et al. Development of tearing in preterm and term neonates. Arch Ophthalmol. 1998;116(6):773–776.
   PubMedGoogle Scholar
• Del Amo EM, Rimpela AK, Heikkinen E, et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retinal Eye Res. 2017;57:134–185.
   PubMed Web of Science ®Google Scholar
• Lim LT, Ah-kee EY, Collins CE. Common eye drops and their implications for pH measurements in the management of chemical eye injuries. Int J Ophthalmol. 2014;7(6):1067–1068.
   PubMed Web of Science ®Google Scholar
• Patamasucon P, Rettig PJ, Faust KL, et al. Oral v topical erythromycin therapies for chlamydial conjunctivitis. Am J Dis Child. 1982;136(9):817–821.
   PubMedGoogle Scholar
• Wahlberg V, Moberg Kallings I, Winberg J. Reconsideration of Credé’s prophylaxis. I. Epidemiologic aspects of gonorrheal and chlamydial infection. Local effects of sliver nitrate and hexarginum. Acta Paediatrica Scand. 1982;s295(s295):27–36.
   Google Scholar
• Fitzgerald HE, McCreal CE. Reconsideration of Credé’s prophylaxis. Introduction. Acta Paediatrica Scand. 1982;s295:9–21.
   Google Scholar
• Kapoor VS, Evans JR, Vedula SS. Interventions for preventing ophthalmia neonatorum (Review). Cochrane Database Syst Rev. 2020;9(CD001862):1–234.
   Google Scholar
• Kreisel K, Weston E, Braxton J, et al. Keeping an eye on chlamydia and gonorrhea conjunctivitis in infants in the United States, 2010-2015. Sex Transm Dis. 2017;44(6):356–358.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Erythromycin (0.5%) ophthalmic ointment shortage (Page last reviewed 2021 May 24). https://www.cdc.gov/std/treatmentdrugnotices/erythromycin-ophthalmic.htm. (Accessed 2022 Feb 17).
   Google Scholar
• Nathawad R, Mendez H, Ahmad A, et al. Severe ocular reactions after neonatal ocular prophylaxis with gentamicin ophthalmic ointment. Pediatr Infect Dis J. 2011;30(2):175–176.
   PubMed Web of Science ®Google Scholar
• Bell TA, Sandström KI, Gravett MG, et al. Comparison of ophthalmic silver nitrate solution and erythromycin ointment for prevention of natally acquired Chlamydia trachomatis. Sex Transm Dis. 1987;14(4):195–200.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. CDC’s STI treatment guidelines timeline: the evolution of sexual healthcare. https://www.cdc.gov/std/treatment-guidelines/timeline.htm. (Accessed 2022 Sept 30).
   Google Scholar
• Gonorrhea. Recommended Treatment Schedules–1974. J Pediatr. 1975;86:794–798.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 1989 CDC STD Treatment Guidelines. Morbid Mortal Weekly Rep MMWR 1989; 38(S–8):i–xi,1–43.
   Google Scholar
• Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. Morbid Mortal Weekly Rep MMWR. 2010;59(RR–12):1–109.
   PubMedGoogle Scholar
• Red Book: 2021 Report of the Committee on Infectious Diseases, 32nd Edition. Kimberlin DW, Barnett ED, Lynfield R, et al., eds. American Academy of Pediatrics.
   Google Scholar
• Ivensky V, Mandel R, Boulay A-C, et al. Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: a retrospective cohort study. Can Commun Dis Rep. 2021;47(4):209–215.
   PubMedGoogle Scholar
• Canadian Notifiable Diseases Surveillance System (CNDSS), Public Health Agency of Canada (PHAC). https://diseases.canada.ca/notifiable/charts?c=cc#c=cc&lang=en_US. Accessed 2022 Oct 4.
   Google Scholar
• Comunián-Carrrasco G, Peña-Martí GE, Martí-Carvajal AJ, et al. Antibiotics for treating gonorrhea in pregnancy. Cochrane Database Syst Rev. 2018 [Accessed 2022 Sept 27];2018(2).
   Google Scholar
• Kohlhoff S, Roblin PM, Clement S, et al. Universal prenatal screening and testing and Chlamydia trachomatis conjunctivitis in infants. Sex Transm Dis. 2021;48(9):e122–e123.
   PubMed Web of Science ®Google Scholar
• Banniettis N, Wisecup K, Byland L, et al. Association of routine Chlamydia trachomatis screening during pregnancy and seroprevalence of chlamydial infection in children, 1991–2015. J Pediatr Infect Dis Soc. 2021;10(2):172–174.
   PubMed Web of Science ®Google Scholar
• FDA Drug Shortages. Cefotaxime sodium injection. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cefotaxime%20Sodium%20Injection&st=c&tab=tabs-1#:~:text=(Reverified%2010%2F14%2F2021)&text=SteriMax%20in%20conjunction%20with%20FDA,%2D877%2D404%2D3338. Accessed 2022 Feb 4.
   Google Scholar
• Galega FP, Heymann DL, Nasah BT. Gonococcal ophthalmia neonatorum: the case for prophylaxis in tropical Africa. Bull World Health Org. 1984;68:95–98.
   Google Scholar
• Medline A, Davey DV, Klausner JD. Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis. Int J STD AIDS. 2017;28(7):660–666.
   PubMed Web of Science ®Google Scholar
• Boadi-Kusi SB, Kyei S, Holdbrook S, et al. A study of ophthalmia neonatorum in the central region of Ghana: causative agents and antibiotic susceptibility patterns. Glob Pediatr Health. 2021;8:1–7.
   Google Scholar
• Grant JS, Chico RM, Lee ACC, et al. Sexually transmitted infections in pregnancy: a narrative review of the global research gaps, challenges, and opportunities. Sex Transm Dis. 2020;47(12):779–789.
   PubMed Web of Science ®Google Scholar